Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

Overview

The global cancer burden is estimated to have risen to 18.1 million new cases in 2018 (WHO), with a trend of ongoing growth. This very frequent illness exerts tremendous physical, emotional and financial strain on individuals, families, communities and health systems.

Malnutrition (under- or over-nutrition) is highly prevalent in cancer patients receiving chemotherapy and is an important predictor of morbidity, mortality, treatment response and toxicity. Alterations in taste and smell are frequently reported as side effect of chemotherapy and may contribute strongly to malnutrition and to a worsen quality of life and wellbeing social, emotional, and role functioning. There are evidences that chemotherapy influences food liking and appetite with implications for food behaviours, including food enjoyment, food preference and dietary intake. A linkage between alterations in taste and /or smell and food behaviours has been reported by some studies but not all, suggesting that there is a need for more research using common standardised methodologies and larger sample size to gain a further insight into this topic.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: January 2022

Interventions

  • Drug: Chemotherapy
    • standard adjuvat chemotherapy for reast and colo cancer

Arms, Groups and Cohorts

  • patients with colon cancer
  • patients with breast cancer

Clinical Trial Outcome Measures

Primary Measures

  • change of taste chemotherapy-related alterations
    • Time Frame: the variables will be measured at four time points: before chemotherapy (T0), after 4 cycles (T1, each cycle is 21 days), at the end of chemotherapy (T2, 6 months from T0) and three months after the conclusion of the therapy (T3, 9 months from T0)
    • To better understand alteration of taste/smell and food behaviours by the self-report responses, using an adapted version of a questionnaire set up to measure taste changes due to COVID-19

Secondary Measures

  • Emotions elicited by foods
    • Time Frame: the variables will be measured at four time points: before chemotherapy (T0), after 4 cycles (T1, each cycle is 21 days), at the end of chemotherapy (T2, 6 months from T0) and three months after the conclusion of the therapy (T3, 9 months from T0)
    • Emotions elicited by foods will be measured on a selection of foods through an EmoSemio questionnaire, a self-report measure of emotion developed based on preliminary interviews

Participating in This Clinical Trial

Inclusion Criteria

  • pathological diagnosis of colorectal or breast cacer
  • indication to adjuvant chemotherapy for colon cancer according local guide lines
  • indication to (neo)-adjuvant chemotherapy for reast cancer according local guide lines
  • possiility to sign an informed consent

Exclusion Criteria

  • patients aged <18 years
  • patients aged >80 years

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Florence
  • Provider of Information About this Clinical Study
    • Principal Investigator: Giandomenico Roviello, Assistant professor, md, phd – University of Florence

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.